Table 2.
Sociodemographic characteristics association with resistance pattern of clinical isolates.
| Characteristics | Ceftazidime | Ceftriaxone | |||||
|---|---|---|---|---|---|---|---|
| R | NR | P-value | R | NR | P-value | ||
| Age in years | ≤19 | 23 | 20 | 0.07622 | 23 | 20 | 0.06902 |
| 20-64 | 80 | 61 | 73 | 68 | |||
| ≥65 | 46 | 18 | 44 | 20 | |||
|
| |||||||
| Sex | Female | 55 | 39 | 0.69326 | 53 | 41 | 0.98641 |
| Male | 94 | 60 | 87 | 67 | |||
|
| |||||||
| Specimen Type | Sputum | 29 | 22 | 0.08527 | 26 | 25 | 0.01426 |
| Urine | 41 | 15 | 41 | 15 | |||
| Wound Swab | 50 | 45 | 45 | 50 | |||
| Stool | 29 | 17 | 28 | 18 | |||
|
| |||||||
| Hospital Stay | ≤1 Days | 35 | 27 | 0.29227 | 30 | 32 | 0.35481 |
| 2-3 Days | 72 | 40 | 66 | 46 | |||
| 4-6 Days | 19 | 20 | 21 | 18 | |||
| ≥7 Days | 23 | 12 | 23 | 12 | |||